Shattuck Labs, Inc. (STTK)
NASDAQ: STTK · Real-Time Price · USD
7.43
+0.34 (4.80%)
At close: Jul 24, 2026, 4:00 PM EDT
7.52
+0.09 (1.21%)
After-hours: Jul 24, 2026, 7:34 PM EDT
Shattuck Labs Market Cap
Shattuck Labs has a market cap or net worth of $569.74 million as of July 24, 2026. Its market cap has increased by 1,351.31% in one year.
Market Cap
569.74M
Enterprise Value
482.21M
1-Year Change
1,351.31%
Ranking
Category
Stock Price
$7.43
ChartMarket Cap Chart
Since the IPO on October 9, 2020, Shattuck Labs's market cap has decreased from $677.31M to $569.74M, a decrease of -15.88%. That is a compound annual growth rate of -2.94%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 569.74M | 146.67% |
| Dec 31, 2025 | 230.97M | 299.85% |
| Dec 31, 2024 | 57.77M | -82.81% |
| Dec 29, 2023 | 336.08M | 244.71% |
| Dec 30, 2022 | 97.50M | -72.88% |
| Dec 31, 2021 | 359.52M | -83.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rezolute | 554.72M |
| Altimmune | 552.31M |
| Relmada Therapeutics | 545.43M |
| Verastem | 543.06M |
| 4D Molecular Therapeutics | 542.63M |
| Silence Therapeutics | 540.83M |
| Contineum Therapeutics | 537.24M |
| Prime Medicine | 536.43M |